Company Profile

CardioDx Inc
Profile last edited on: 11/17/2023      CAGE: 62J19      UEI: ECJ7K2CQSZF5

Business Identifier: Cardiovascular genomic diagnostics
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

600 Saginaw Drive
Redwood City, CA 94063
   (650) 475-2788
Location: Single
Congr. District: 15
County: San Mateo

Public Profile

In a somewhat unexpected move, in January 2019 it was reported that CardioDX had laid off all 110 workers and close operations. This decision was made shortly after decision was made public in late 2018 by Medicare that they would no longer cover the firm's lead product: a bllod test for heart disease. CardioDx had been a biotechnology and diagnostics company specializing in cardiovascular genomic diagnostics. A molecular diagnostics company, CardioDx develops tested for coronary artery disease (CAD), cardiac arrhythmia, and heart failure. Using clinically-validated tests that allowed clinicians better tto ailor care to each individual patient, CardioDX's prime product was the Corus CAD, a blood test which allows physicians to determine if a patients chest discomfort is due to obstructive coronary artery disease. Corus CAD is a gene expression test (not a genetic test) that examines the expression changes associated with atherosclerosis. In addition to the Corus CAD, CardioDx had been investigating other diagnostics for cardiac arrhythmia and heart failure.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Publicly Traded
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2014 1 NIH $205,804
Project Title: Development of a Matrix-Based Platform for the Collection and Storage of Nucleic

Key People / Management

  David Levison -- President, Chief Executive Officer; Founder

  David Chernoff -- Chief Medical Officer

  Susan Daniels -- Vice President, Development

  Deborah Kilpatrick -- Chief Commerical Officer

  Mark Monane -- Chief Medical Officer

  James Alan Wingrove